Related Experiment Video

Updated: Aug 2, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Management of patients with virologic and metabolic failure

Daniel R Kuritzkes1

  • 1Harvard Medical School, Brigham and Women's Hospital, Boston, USA.

The AIDS Reader
|July 4, 2003
PubMed

Insights

Managing HIV treatment failure requires careful drug selection. Resistance testing guides the choice of effective salvage therapy, considering drug resistance, toxicities, and patient factors for optimal outcomes.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Virology

Background:

  • Managing HIV treatment failure presents challenges due to drug resistance and metabolic complications.
  • Current anti-HIV therapies can lead to toxicities like hyperlipidemia and lipodystrophy.
  • Salvage therapy selection is often limited by cross-resistance among antiretroviral agents.

Purpose of the Study:

  • To review the role of resistance testing in guiding salvage therapy for HIV.
  • To discuss the challenges and opportunities in managing virologic failure in HIV treatment.
  • To highlight the importance of novel agents and combination strategies for treatment-experienced patients.

Main Methods:

  • Review of current literature on HIV drug resistance and salvage therapy.
  • Analysis of the impact of resistance testing on treatment selection.
  • Evaluation of novel antiretroviral agents and combination regimens.

Main Results:

  • Resistance testing is crucial for selecting effective agents in salvage therapy.
  • Newer antiretroviral drugs show efficacy in treatment-experienced patients with failing regimens.
  • Partially active drugs can be combined to form effective background regimens against resistant HIV.

Conclusions:

  • Individualized treatment approaches are necessary, considering resistance patterns, toxicities, and patient factors.
  • Careful regimen selection, guided by resistance testing, is key to sustaining long-term HIV treatment benefits.
  • The development of new drugs and strategic combinations offers improved options for managing complex HIV cases.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...